TX-MARY-KAY-INC.
Mary Kay Inc., a global leader in corporate sustainability and advocacy, today released its 2024 Sustainability Report. The report—which is organized by environmental, social, and economic impact—underscores the company’s commitment to creating and nurturing a business model that enriches women’s lives and supports communities while protecting our planet.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240723781468/en/
Mary Kay’s 2024 Sustainability report, released in July, is organized by environmental, social, and economic impact. It underscores the company’s commitment to creating and nurturing a business model that enriches women’s lives and supports communities while protecting our planet. (Photo credit: Mary Kay).
“Sustainability has deep roots in the Mary Kay story,” said Deborah Gibbins, Chief Operating Officer at Mary Kay Inc. “We like to say we did it before it was ‘cool.’ Our iconic founder, Mary Kay Ash, was passionate about not only changing the world, but protecting it. I’m proud of the work we’ve accomplished this year—and every year—in realizing her dream. I think she would be proud, too.”
In a world that is rapidly evolving, Mary Kay stands at the forefront of change, championing the cause of women while recognizing the immense power they hold in shaping our global economy and driving meaningful change.
The 2024 report highlights Mary Kay’s promise to make decisions that are right for our planet and its people:
Environmental Sustainability
- Water Stewardship: Partnering with The Nature Conservancy for over 36 years, Mary Kay supports the "Super Reefs" initiative to protect resilient coral reefs.
- Resource Conservation: Through a 16-year partnership with the Arbor Day Foundation, Mary Kay has supported the planting of over 1.4 million trees in reforestation projects across nine countries.
- Sustainable Sourcing: Joining the Global Shea Alliance, Mary Kay promotes economic well-being for the 16 million women Shea collectors in West Africa.
Social Sustainability
- Pink Changing Lives: Through this program, funded by designated product sales, Mary Kay has donated over $18 million to initiatives enriching women's lives worldwide since 2008.
- Women’s Empowerment: On International Women’s Day, Mary Kay joined the Women’s Empowerment Principles (WEPs), a set of Principles offering guidance to businesses on how to advance gender equality and women’s empowerment in the workplace, marketplace, and community. More than 600,000 women have benefitted from the trainings, events, and programs offered by the Women’s Entrepreneurship Accelerator, launched by Mary Kay in partnership with six United Nations agencies in 2019.
- Fostering Women in STEM: Committed to the development of the next generation of women STEM leaders, Mary Kay has awarded 29 grants totaling nearly $195,000 since 2020.
Economic Sustainability
- Celebrating 60 years: Mary Kay Ash’s vision of enriching women’s lives continues. Mary Kay, still family-owned and -led, has blossomed into a global brand with nearly 4,000 employees and millions of Mary Kay Independent Beauty Consultants in more than 35 markets. For more than 60 years, Mary Kay has provided an unparalleled entrepreneurship opportunity for women around the world. The company was named the #1 Direct Selling brand of Skin Care and Color Cosmetics in the World by Euromonitor International1.
- Digital Innovation: Mary Kay enhances the capabilities of Independent Beauty Consultants through digital tools, including augmented reality apps and the Interactive Catalog, allowing them to excel in their businesses and realize their dreams.
- Advocacy for Gender Equality in AI: Partnering with the Equal Rights Trust, Mary Kay pioneered research to eliminate gender bias in AI technologies.
For further insights into Mary Kay’s global sustainability strategy, engagement, and impact, view the full report here.
About Mary Kay
Then. Now. Always. One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty brand in Texas in 1963 with one goal: to enrich women’s lives. That dream has blossomed into a global company with millions of independent sales force members in more than 35 countries. For 60 years, the Mary Kay opportunity has empowered women to define their own futures through education, mentorship, advocacy, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in preserving our planet for future generations, protecting women impacted by cancer and domestic abuse, and encouraging youth to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn, or follow us on X (formerly known as Twitter).
1 “Source Euromonitor International Limited; Beauty and Personal Care 2023 Edition, value sales at RSP, 2022 data.”
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240723781468/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom